![Elham Hershberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Elham Hershberger worked as the President of Emh Consulting Group, Inc. from 2017 to 2020.
She was also the Head-Clinical Development at Visterra, Inc. from 2016 to 2017 and the Chief Development Officer at Invivyd, Inc. from 2020 to 2022.
Dr. Hershberger holds a doctorate degree from Ferris State University (Michigan) and an undergraduate degree from the University of Minnesota.
Anciens postes connus de Elham Hershberger
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVYD, INC. | Corporate Officer/Principal | 06/12/2022 |
Emh Consulting Group, Inc. | President | 01/10/2020 |
| VISTERRA INC | Corporate Officer/Principal | 01/07/2017 |
Formation de Elham Hershberger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Emh Consulting Group, Inc. |
